Pioneering in vivo gene therapy for lasting impact
In vivo gene therapy directly delivers therapeutic genetic material to cells within the patient’s body. By using viral or non-viral vectors, gene therapy can correct genetic mutations or introduce new genes to fight diseases. Unlike ex vivo therapies, in vivo gene therapies are typically administered through injection or infusion and target specific cells in situ, often requiring only a single treatment.
At Revvity, we provide the essential technologies for in vivo gene therapy development, from viral vector production to delivery and safety testing, supporting successful and precise therapeutic outcomes.
For Research Use Only. Not for use in diagnostic procedures.
